{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:57:33Z","timestamp":1778090253434,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2023R1A2C2002380"],"award-info":[{"award-number":["NRF-2023R1A2C2002380"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.intimp.2024.111800","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T23:23:51Z","timestamp":1709594631000},"page":"111800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["NJK14047 inhibition of p38 MAPK ameliorates inflammatory immune diseases by suppressing T cell differentiation"],"prefix":"10.1016","volume":"130","author":[{"given":"Ju-Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1928-2288","authenticated-orcid":false,"given":"So-Eun","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hwan","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8054-8946","authenticated-orcid":false,"given":"Dong-Soon","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.111800_b0005","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.intimp.2024.111800_b0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis\u2013epidemiology and clinical spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin. Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2024.111800_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2024.111800_b0020","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.intimp.2024.111800_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041291","article-title":"The burden of rheumatoid arthritis: findings from the 2019 global burden of diseases study and forecasts for 2030 by Bayesian age-period-cohort analysis","volume":"12","author":"Cai","year":"2023","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.111800_b0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40257-013-0032-x","article-title":"Burden of disease: psoriasis and psoriatic arthritis","volume":"14","author":"Boehncke","year":"2013","journal-title":"Am. J. Clin. Dermatol."},{"issue":"9","key":"10.1016\/j.intimp.2024.111800_b0035","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.111800_b0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1586\/eci.11.4","article-title":"Ustekinumab for the treatment of psoriasis","volume":"7","author":"Laws","year":"2011","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.111800_b0045","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1124\/jpet.105.100362","article-title":"Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction","volume":"317","author":"Mbalaviele","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.intimp.2024.111800_b0050","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.4049\/jimmunol.162.7.4246","article-title":"Differential expression and activation of p38 mitogen-activated protein kinase \u03b1, \u03b2, \u03b3, and \u03b4 in inflammatory cell lineages","volume":"162","author":"Hale","year":"1999","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.111800_b0055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.coph.2004.03.009","article-title":"The p38 MAP kinase pathway as a therapeutic target in inflammatory disease","volume":"4","author":"Saklatvala","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"issue":"40","key":"10.1016\/j.intimp.2024.111800_b0060","doi-asserted-by":"crossref","first-page":"31155","DOI":"10.1074\/jbc.M001229200","article-title":"Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL)","volume":"275","author":"Matsumoto","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2024.111800_b0065","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2007.074278","article-title":"The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis","volume":"67","author":"Schett","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2024.111800_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061346","article-title":"Roles of cyclic AMP response element binding activation in the ERK1\/2 and p38 MAPK signalling pathway in central nervous system, cardiovascular system, osteoclast differentiation and mucin and cytokine production","volume":"20","author":"Koga","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2024.111800_b0075","doi-asserted-by":"crossref","first-page":"L895","DOI":"10.1152\/ajplung.2000.279.5.L895","article-title":"SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung","volume":"279","author":"Underwood","year":"2000","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.intimp.2024.111800_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41927-017-0001-8","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets","volume":"1","author":"Alunno","year":"2017","journal-title":"BMC Rheumatol"},{"issue":"1","key":"10.1016\/j.intimp.2024.111800_b0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/prd.12083","article-title":"Basic biology and role of interleukin-17 in immunity and inflammation","volume":"69","author":"Zenobia","year":"2015","journal-title":"Periodontol 2000"},{"key":"10.1016\/j.intimp.2024.111800_b0090","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fmed.2018.00364","article-title":"IL-17 in rheumatoid arthritis and precision medicine: from synovitis expression to circulating bioactive levels","volume":"5","author":"Robert","year":"2018","journal-title":"Front Med (lausanne)"},{"issue":"1","key":"10.1016\/j.intimp.2024.111800_b0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"issue":"suppl_2","key":"10.1016\/j.intimp.2024.111800_b0100","doi-asserted-by":"crossref","first-page":"ii64","DOI":"10.1093\/rheumatology\/kew347","article-title":"Stable activation of fibroblasts in rheumatic arthritis\u2014causes and consequences","volume":"55","author":"Korb-Pap","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.intimp.2024.111800_b0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2133.2004.06304.x","article-title":"The mitogen-activated protein kinases p38 and ERK1\/2 are increased in lesional psoriatic skin","volume":"152","author":"Johansen","year":"2005","journal-title":"Br. J. Dermatol."},{"issue":"41","key":"10.1016\/j.intimp.2024.111800_b0110","doi-asserted-by":"crossref","first-page":"28420","DOI":"10.1074\/jbc.M109.012674","article-title":"Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice","volume":"284","author":"Cui","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2024.111800_b0115","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.18632\/oncotarget.6535","article-title":"GITRL modulates the activities of p38 MAPK and STAT3 to promote Th17 cell differentiation in autoimmune arthritis","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.111800_b0120","doi-asserted-by":"crossref","first-page":"5980190","DOI":"10.1155\/2020\/5980190","article-title":"Immune regulation of TNFAIP3 in psoriasis through its association with Th1 and Th17 cell differentiation and p38 activation","volume":"2020","author":"Jiang","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2024.111800_b0125","doi-asserted-by":"crossref","first-page":"6187695","DOI":"10.1155\/2021\/6187695","article-title":"Shentong zhuyu decoction inhibits inflammatory response, migration, and invasion and promotes apoptosis of rheumatoid arthritis fibroblast-like synoviocytes via the MAPK p38\/PPAR\u03b3\/CTGF pathway","volume":"2021","author":"Han","year":"2021","journal-title":"Biomed Res. Int."},{"issue":"8","key":"10.1016\/j.intimp.2024.111800_b0130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11626-023-00810-1","article-title":"In vitro inhibitory effect of zingerone on TNF\u03b1-stimulated fibroblast-like synoviocytes","volume":"59","author":"Mao","year":"2023","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.intimp.2024.111800_b0135","first-page":"1","article-title":"Icariin decreases cell proliferation and inflammation of rheumatoid arthritis-fibroblast like synoviocytes via GAREM1\/MAPK signaling pathway","author":"Wu","year":"2023","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"17","key":"10.1016\/j.intimp.2024.111800_b0140","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1016\/j.bmcl.2015.06.036","article-title":"Synthesis and biological evaluation of N-cyclopropylbenzamide-benzophenone hybrids as novel and selective p38 mitogen activated protein kinase (MAPK) inhibitors","volume":"25","author":"Heo","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.intimp.2024.111800_b0145","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1111\/jcmm.16854","article-title":"Activation of formyl peptide receptor 1 elicits therapeutic effects against collagen-induced arthritis","volume":"25","author":"Park","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.intimp.2024.111800_b0150","article-title":"Free fatty acid receptor 4 (FFA4) activation ameliorates imiquimod-induced psoriasis in mice","volume":"23","author":"Son","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.111800_b0155","doi-asserted-by":"crossref","first-page":"e12712","DOI":"10.1111\/sji.12712","article-title":"Acacetin regulated the reciprocal differentiation of Th17 cells and Treg cells and mitigated the symptoms of collagen-induced arthritis in mice","volume":"88","author":"Liu","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2024.111800_b0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13020-020-00311-3","article-title":"Pien Tze Huang alleviate the joint inflammation in collagen-induced arthritis mice","volume":"15","author":"Deng","year":"2020","journal-title":"Chin. Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.111800_b0165","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/annrheumdis-2020-219247","article-title":"'SMASH' recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models","volume":"80","author":"Hayer","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2024.111800_b0170","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/ard.2010.141077","article-title":"Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis","volume":"70","author":"Corr","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.111800_b0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00281-003-0131-5","article-title":"The KRN mouse model of inflammatory arthritis","volume":"25","author":"Kyburz","year":"2003","journal-title":"Springer Semin. Immunopathol."},{"issue":"4","key":"10.1016\/j.intimp.2024.111800_b0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.20021850","article-title":"Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling","volume":"197","author":"Choe","year":"2003","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.111800_b0185","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar1028","article-title":"Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols","volume":"6","author":"Douni","year":"2004","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2024.111800_b0190","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2024.111800_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/569751","article-title":"The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis","volume":"2013","author":"Mavropoulos","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.111800_b0200","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/art.24485","article-title":"Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies","volume":"60","author":"Damjanov","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.intimp.2024.111800_b0205","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/jm9012906","article-title":"Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders","volume":"53","author":"Goldstein","year":"2010","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2024.111800_b0210","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2019.06.019","article-title":"Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis","volume":"144","author":"Sakurai","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.111800_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115973","article-title":"Function and inhibition of P38 MAP kinase signaling: targeting multiple inflammation diseases","volume":"220","author":"Wang","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2024.111800_b0220","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd.2018.21","article-title":"Kinase inhibitors: the road ahead","volume":"17","author":"Ferguson","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.intimp.2024.111800_b0225","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/13543776.2020.1749263","article-title":"An updated patent review of p38 MAP kinase inhibitors (2014\u20132019)","volume":"30","author":"Haller","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"5","key":"10.1016\/j.intimp.2024.111800_b0230","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3899\/jrheum.100602","article-title":"A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis","volume":"38","author":"Genovese","year":"2011","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2024.111800_b0235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/art.24266","article-title":"Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis","volume":"60","author":"Cohen","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.intimp.2024.111800_b0240","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10787-019-00593-6","article-title":"Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor skepinone-L and the dual p38\/JNK 3 inhibitor LN 950 in experimental K\/BxN serum transfer arthritis","volume":"27","author":"Guenthoer","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2024.111800_b0245","article-title":"Inhibition against p38\/MEF2C pathway by pamapimod protects osteoarthritis chondrocytes hypertrophy","author":"Zhang","year":"2020","journal-title":"Panminerva Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.111800_b0250","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4062\/biomolther.2022.078","article-title":"NJK14047 suppression of the p38 MAPK ameliorates OVA-induced allergic asthma during sensitization and challenge periods","volume":"31","author":"Lee","year":"2023","journal-title":"Biomol Ther (seoul)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924003187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924003187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:16:17Z","timestamp":1761588977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924003187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":50,"alternative-id":["S1567576924003187"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111800","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NJK14047 inhibition of p38 MAPK ameliorates inflammatory immune diseases by suppressing T cell differentiation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111800"}}